Trial Profile
Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix) in Infants.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine live oral
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 09 Jul 2010 Actual number of patients added to 1101 as reported by ClinicalTrials.gov.
- 09 Jul 2010 Planned end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 09 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.